EditCo Bio
PrivateLast Round
VC Round
Mar 27, 2024
Company Overview
EditCo Bio is a biotechnology company that provides CRISPR-engineered cell models and high-throughput gene editing solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EditCo Bio Comps
Public and private peers based on sector, stage, and business model.
EditCo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 27, 2024 |
Key People
Founding team and executive leadership
EditCo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Telegraph Hill Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 119% MoM, reaching 19.3K.
- Nov 27, 2024
Grew 16% QoQ, from 79 to 92 employees.
EditCo Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EditCo Bio's valuation, stock price, and market status.
